Home/Filings/4/0001062993-25-010396
4//SEC Filing

BRYNELSEN CHARLES 4

Accession 0001062993-25-010396

CIK 0001840877other

Filed

May 26, 8:00 PM ET

Accepted

May 27, 6:34 PM ET

Size

10.4 KB

Accession

0001062993-25-010396

Insider Transaction Report

Form 4
Period: 2025-05-22
Transactions
  • Purchase

    Class A Common Stock

    2025-05-27$1.65/sh+35,000$57,67350,000 total
  • Purchase

    Class A Common Stock

    2025-05-22$1.68/sh+2,000$3,3672,000 total
  • Purchase

    Class A Common Stock

    2025-05-23$1.64/sh+13,000$21,36315,000 total
Holdings
  • Stock Option (right to buy)

    Exercise: $2.40Exp: 2033-10-15Class A Common Stock (62,500 underlying)
    62,500
Footnotes (4)
  • [F1]The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $1.6875 to $1.6794 inclusive. The reporting person undertakes to provide Envoy Medical, Inc., any security holder of Envoy Medical, Inc., or the staff of the Securities and Exchange Commission upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote.
  • [F2]The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $1.6333 to $1.6497 inclusive. The reporting person undertakes to provide Envoy Medical, Inc., any security holder of Envoy Medical, Inc., or the staff of the Securities and Exchange Commission upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote.
  • [F3]The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $1.6345 to $1.65 inclusive. The reporting person undertakes to provide Envoy Medical, Inc., any security holder of Envoy Medical, Inc., or the staff of the Securities and Exchange Commission upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote.
  • [F4]Options to purchase 46,875 shares vest on 10/15/2023, and the remaining 15,625 shares vest pro rata on the 15th of each month thereafter for 36 consecutive months.

Issuer

Envoy Medical, Inc.

CIK 0001840877

Entity typeother

Related Parties

1
  • filerCIK 0001712459

Filing Metadata

Form type
4
Filed
May 26, 8:00 PM ET
Accepted
May 27, 6:34 PM ET
Size
10.4 KB